Showing 4153 results for "als"

Flex Pharma Shifts Focus to Programs Targeting ALS, Other Neurological Diseases

Flex Pharma said it plans to prioritize developing its clinical programs in neurological diseases, including amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and peripheral neuropathies like Charcot-Marie Tooth (CMT). One or two proof-of-concept, Phase 2 clinical trials are planned for this year in the United States to evaluate the company’s transient receptor…

8 Medical Management Areas for ALS Patients

The advancements in both technology and medicine means that managing symptoms of ALS is now easier than ever before. Doctors are able to make patients much more comfortable and improve their quality of life. There are various areas of medical management needed for people with amyotrophic lateral sclerosis (ALS) and we’ve listed…

How Has Stephen Hawking Lived So Long With ALS?

Stephen Hawking is, without a doubt, the most famous person with amyotrophic lateral sclerosis (ALS). He’s so incredibly famous for two main reasons: firstly, he’s a brilliant scientist. He’s changed the world’s understanding of space, made history with his papers on the Big Bang Theory and wrote a bestselling book A Brief History…

5 Misconceptions About ALS You Might Find Interesting

Amyotrophic lateral sclerosis (ALS) is sometimes known as Lou Gehrig disease after the baseball player who famously suffered from it. Although ALS is a more common disease than we would like it to be, there is still little known about it and many are unaware of the details of the condition. That lack of…

Cholesterol-Related Molecule May Be Linked to ALS Progression

High levels of 25-hydroxycholesterol, a cholesterol-related molecule, may trigger neuronal death and accelerate amyotrophic lateral sclerosis (ALS) progression, according to a new study. The finding could lead to new ALS therapies that target the molecule. The study, “25-Hydroxycholesterol Is Involved In The Pathogenesis Of Amyotrophic Lateral Sclerosis,” was published in the…